Scpharmaceuticals Inc (SCPH) — Financial Flexibility Index
Scpharmaceuticals Inc (SCPH) has a Financial Flexibility Index of -0.16x as of June 2025. Free cash flow of $-16.11 Million (operating CF $-16.11 Million minus capex $0.00) represents 0% of total liabilities ($101.57 Million). Check how strategically is Scpharmaceuticals Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Scpharmaceuticals Inc Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Scpharmaceuticals Inc across 10 annual periods. See working capital position of Scpharmaceuticals Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Scpharmaceuticals Inc (2015–2024)
Year-by-year free cash flow to debt coverage for Scpharmaceuticals Inc. For the full company profile including market capitalisation, see Scpharmaceuticals Inc stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.75x | $-70.52 Million | $-70.54 Million | $94.20 Million | ▲ +27.6% |
| 2023 | -1.03x | $-59.20 Million | $-59.24 Million | $57.26 Million | ▼ -54.9% |
| 2022 | -0.67x | $-34.56 Million | $-34.58 Million | $51.76 Million | ▲ +44.5% |
| 2021 | -1.20x | $-27.14 Million | $-27.15 Million | $22.57 Million | ▼ -16.8% |
| 2020 | -1.03x | $-27.68 Million | $-27.69 Million | $26.88 Million | ▲ +12.3% |
| 2019 | -1.17x | $-30.43 Million | $-30.44 Million | $25.92 Million | ▲ +38.8% |
| 2018 | -1.92x | $-28.80 Million | $-28.81 Million | $15.01 Million | ▼ -37.0% |
| 2017 | -1.40x | $-22.49 Million | $-22.68 Million | $16.05 Million | ▼ -597.0% |
| 2016 | -0.20x | $-15.45 Million | $-15.46 Million | $76.85 Million | ▲ +58.0% |
| 2015 | -0.48x | $-9.62 Million | $-9.64 Million | $20.09 Million | — |